Abstract

BackgroundPreprints are preliminary reports that have not been peer-reviewed. In December 2019, a novel coronavirus appeared in China, and since then, scientific production, including preprints, has drastically increased. In this study, we intend to evaluate how often preprints about COVID-19 were published in scholarly journals and cited.MethodsWe searched the iSearch COVID-19 portfolio to identify all preprints related to COVID-19 posted on bioRxiv, medRxiv, and Research Square from January 1, 2020, to May 31, 2020. We used a custom-designed program to obtain metadata using the Crossref public API. After that, we determined the publication rate and made comparisons based on citation counts using non-parametric methods. Also, we compared the publication rate, citation counts, and time interval from posting on a preprint server to publication in a scholarly journal among the three different preprint servers.ResultsOur sample included 5,061 preprints, out of which 288 were published in scholarly journals and 4,773 remained unpublished (publication rate of 5.7%). We found that articles published in scholarly journals had a significantly higher total citation count than unpublished preprints within our sample (p < 0.001), and that preprints that were eventually published had a higher citation count as preprints when compared to unpublished preprints (p < 0.001). As well, we found that published preprints had a significantly higher citation count after publication in a scholarly journal compared to as a preprint (p < 0.001). Our results also show that medRxiv had the highest publication rate, while bioRxiv had the highest citation count and shortest time interval from posting on a preprint server to publication in a scholarly journal.ConclusionsWe found a remarkably low publication rate for preprints within our sample, despite accelerated time to publication by multiple scholarly journals. These findings could be partially attributed to the unprecedented surge in scientific production observed during the COVID-19 pandemic, which might saturate reviewing and editing processes in scholarly journals. However, our findings show that preprints had a significantly lower scientific impact, which might suggest that some preprints have lower quality and will not be able to endure peer-reviewing processes to be published in a peer-reviewed journal.

Highlights

  • Preprints are preliminary reports that have not been peer-reviewed

  • Preprints should be used as a mean to display preliminary data rapidly in order to obtain feedback by the scientific community, or to guide further research

  • We conducted a search to identify preprints on pharmacological interventions for COVID-19 posted in medRxiv and bioRxiv from January 1st to March 31, 2020

Read more

Summary

Introduction

Preprints are preliminary reports that have not been peer-reviewed. A preprint is a preliminary report that is shared publicly before it has been peer-reviewed. There are multiple servers that host preprints, notably including bioRxiv and medRxiv, operated by Cold Spring Harbor Laboratory. Advocates of preprints claim that this medium can accelerate access to science findings and improve quality of published works by permitting faster feedback of the work by the scientific community before publishing. As well, they argue that the audience for preprints is larger, because many articles published in peer-reviewed journals do not have open access [2]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call